Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients

Journal of Cachexia, Sarcopenia and Muscle

Volumn 3, Issue 3, 2012, Pages 191-198

  Solheim, Tora S ^a,b   Fayers, Peter M ^a,c   Fladvad, Torill ^a   Tan, Ben ^d   Skorpen, Frank ^a   Fearon, Kenneth ^d   Baracos, Vickie E ^e   Klepstad, Pål ^b,f   Strasser, Florian ^g   Kaasa, Stein ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF ALBERTA   (Canada)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

Author keywords

Anorexia; Appetite loss; Cachexia; Cancer; Genetic; SNP

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER PATIENT; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84865736702     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-012-0064-8     Document Type: Article

References (32)

1. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer. 2002; 2: 862-71.
2. Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008; 44: 1124-32.
3. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12: 489-495.
4. Sarhill N, Mahmoud FA, Christie R, Tahir A. Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hosp Palliat Care. 2003; 20: 465-73.
5. Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1, 000 outpatients. Support Care Cancer. 2009; 17: 279-84.
6. Fordy C, Glover C, Henderson DC, Summerbell C, Wharton R, Allen-Mersh TG. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. Br J Surg. 1999; 86: 639-44.
7. Laviano A, Meguid MM, Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol. 2003; 4: 686-94.
8. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009; 10: 865-71.
9. Lis CG, Gupta D, Grutsch JF. Can anorexia predict patient satisfaction with quality of life in advanced cancer? Support Care Cancer. 2009; 17: 129-35.
10. Davis MP, Dreicer R, Walsh D, Lagman R, LeGrand SB. Appetite and cancer-associated anorexia: a review. J Clin Oncol. 2004; 22: 1510-7.
11. Shragge JE, Wismer WV, Olson KL, Baracos VE. The management of anorexia by patients with advanced cancer: a critical review of the literature. Palliat Med. 2006; 20: 623-9.
12. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008; 322: 881-8.
13. Rosado EL, Bressan J, Martins MF, Cecon PR, Martinez JA. Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite. 2007; 49: 635-43.
14. Tanofsky-Kraff M, Han JC, Anandalingam K, Shomaker LB, Columbo KM, Wolkoff LE, et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr. 2009; 90: 1483-8.
15. Helder SG, Collier DA. The genetics of eating disorders. Curr Top Behav Neurosci. 2011; 6: 157-175.
16. Jatoi A, Qi Y, Kendall G, Jiang R, McNallan S, Cunningham J, et al. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Canc. 2009; 15: 15.
17. Jatoi A, Nguyen PL, Foster N, Sun D, Stella PJ, Campbell M, et al. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol. 2007; 5: 41-6.
18. Rausch SM, Clark MM, Patten C, Liu H, Felten S, Li Y et al. Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer. 2010; 116: 4103-4113.
19. Knoll S, Zimmer S, Hinney A, Scherag A, Neubauer A, Hebebrand J. Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia. BMC Cancer. 2008; 8: 85.
20. Klepstad P FT, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S on behalf of the European Palliative Care Research Collaborative (EPCRC) and the European Association for Palliative Care Research Network. The influence from genetic variability on opioid use for cancer pain. An European study of 2294 cancer pain patients. Pain. 2011; 152: 1139-1145.
21. Aaronson NK, Ahmedzai S, Bergman B. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Canc Inst. 1993; 85: 365-76.
22. Fayers P AN, Bjordal K, Sullivan M. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life, Brussels. 1995; 1-49.
23. Langhans W. Signals generating anorexia during acute illness. Proc Nutr Soc. 2007; 66: 321-30.
24. Gosnell BA, Levine AS. Reward systems and food intake: role of opioids. Int J Obes (Lond). 2009; 33(Suppl 2): S54-S58.
25. Benjamini YHY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995; 57: 289-300.
26. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002; 4: 45-61.
27. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29: 154-159.
28. Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Canc. 2009; 18: 433-7.
29. Ueda N, Yoshimura R, Shinkai K, Sakata Y, Nakamura J. Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. Neuropsychobiology. 2003; 48: 31-4.
30. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008; 8: 887-99.
31. Valentine RJ, Woods JA, McAuley E, Dantzer R, Evans EM. The associations of adiposity, physical activity and inflammation with fatigue in older adults. Brain Behav Immun. 2011; 25: 1482-1490.
32. von Haehling SMJ, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.